Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Tuesday, February 27, 2018
Sherpa Clinical Packaging announced new Active Pharmaceutical Ingredient (API) sampling and storage services.
read more
SGS Life Science Services, the leading pharmaceutical analytical and bioanalytical contract solutions provider, today announced that is to expand its Shanghai, China, cGMP chemistry and microbiology laboratories to 2000 square meter by Q2 2015 and ...
read more
SeraNovo has signed a second License Agreement with Carna Biosciences.
read more
Thursday, February 18, 2021
SCYNEXIS has entered into a licensing agreement and strategic partnership with Hansoh Pharmaceutical Group.
read more
Tuesday, October 31, 2017
Sawai has entered into an exclusive agreement with AstraZeneca to manufacture and market Zomig Tablets Zomig Rapid Melt Tablets, a migraine medication in Japan.
read more
Tuesday, February 25, 2020
Sanofi plans to create a European company dedicated to the production and marketing to third parties of active pharmaceutical ingredients (APIs).
read more
Monday, December 16, 2019
Sanofi Pasteur has entered into an agreement with the U.S. HHS to increase the company's domestic pandemic influenza vaccine production capabilities.
read more
Sandoz has announced plans for a joint investment, together with the Austrian federal government, to strengthen the long-term future of integrated antibiotics manufacturing in Europe.
read more
Monday, November 11, 2019
Samsung Biologics announced the signing of a long-term agreement with Ichnos Sciences for manufacturing drug substance for ISB 830.
read more
Monday, September 28, 2020
Samsung Biologics has entered into a service agreement with Panolos Bioscience to develop PB101, an Fc-fusion protein intended to treat solid tumors.
read more
Samsung Biologics entered into a strategic partnership with PharmAbcine for the development and manufacturing of PMC-402 pipeline.
read more
Monday, February 11, 2019
Samsung Bioepis announced its expansion in mainland China through a licensing agreement with C-Bridge Capital.
read more
Thursday, December 03, 2020
Samsung Bioepis and Biogen announced the FDA has accepted for review the BLA for SB11, a proposed biosimilar referencing Lucentis.
read more
Wednesday, November 06, 2019
Samsung Bioepis has entered into a new commercialization agreement with Biogen for two biosimilar candidates under development by Samsung Bioepis, SB11 (ranibizumab) and SB15 (aflibercept).
read more
ST. LOUIS, March 5, 2013 /PRNewswire/ -- Sigma-Aldrich Corporation (NASDAQ: SIAL) today announced that its custom manufacturing and services business unit, SAFC (www.safcglobal.com), is expanding its line of PharmaGrade products with the addition of ...
read more